Management of Pediatric and Adolescent Rhabdomyosarcoma of the Chest Wall: An Expert Consensus Opinion From the

Andreas Schmidt1, Gabriela Guillén2, Leo Y Luo3

  • 1Department of Pediatric Surgery and Pediatric Urology, University Children's Hospital Tuebingen, Tuebingen, Germany.

Pediatric Blood & Cancer
|October 28, 2025
PubMed

Insights

The International Soft-Tissue Sarcoma Consortium (INSTRuCT) offers expert treatment guidelines for pediatric chest wall rhabdomyosarcoma. This consensus document details optimal clinical management from diagnosis to long-term follow-up.

Area of Science:

  • Pediatric Oncology
  • Clinical Sarcoma Research
  • Evidence-Based Medicine

Background:

  • The International Soft-Tissue Sarcoma Consortium (INSTRuCT) unites global pediatric sarcoma groups.
  • INSTRuCT aims to develop consensus expert opinions for effective clinical treatment.
  • Rhabdomyosarcoma of the chest wall is a rare pediatric malignancy requiring specialized care.

Purpose of the Study:

  • To provide evidence-based treatment recommendations for pediatric chest wall rhabdomyosarcoma.
  • To establish consensus guidelines for optimal clinical management.
  • To guide multidisciplinary care including staging, biopsy, local control, and follow-up.

Main Methods:

  • Development of consensus expert opinions through a global partnership (INSTRuCT).
  • Review and synthesis of existing evidence for treatment strategies.
  • Inclusion of guidelines for staging, biopsy, local control, radiation therapy, surgery, lymph node evaluation, reconstruction, and follow-up.

Main Results:

  • Comprehensive evidence-based treatment recommendations for chest wall rhabdomyosarcoma.
  • Detailed guidelines covering all aspects of patient management.
  • Standardized approach to diagnosis and treatment across participating international groups.

Conclusions:

  • This consensus document establishes a framework for optimal clinical treatment of pediatric chest wall rhabdomyosarcoma.
  • The guidelines aim to improve outcomes through standardized, evidence-based care.
  • INSTRuCT's collaborative effort provides a vital resource for clinicians managing this rare tumor.